Even after purification, trace amounts of host cell DNA can remain in biopharmaceutical products. But how much is acceptable, which regulations apply, and why is accurate quantification so important?
Our latest article explains the role of residual DNA testing in biopharmaceutical quality control, the current regulatory expectations, and the analytical methods used to ensure product safety.
|
